You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,667,775


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,667,775
Title: Phosphate-binding polymers for oral administration
Abstract:Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.
Inventor(s): Holmes-Farley; Stephen Randall (Arlington, MA), Mandeville, III; W. Harry (Lynnfield, MA), Whitesides; George M. (Newton, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:08/471,747
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,667,775: A Comprehensive Guide

Introduction

United States Patent 5,667,775, titled "Phosphate-binding polymers for oral administration," is a significant patent in the field of pharmaceuticals and biomedical engineering. This patent, issued to the assignee Roussel Uclaf, describes innovative phosphate-binding polymers designed to remove phosphate from the gastrointestinal tract. Here, we will delve into the scope and claims of this patent and analyze its position within the broader patent landscape.

Patent Overview

Publication Number and Authority

The patent, US5667775A, was published by the United States Patent and Trademark Office (USPTO) and is now expired, having completed its lifetime[4].

Prior Art and Background

The invention builds on prior art related to crosslinking agents, polymers, and compositions for phosphate binding. The patent specifies the use of particular repeating units and counterions to achieve the desired phosphate-binding properties[4].

Scope of the Patent

Claims Analysis

The patent includes multiple claims that define the scope of the invention. Here are some key aspects:

  • Independent Claims: The patent has several independent claims that outline the composition and structure of the phosphate-binding polymers. For example, Claim 1 describes a copolymer characterized by specific repeating units and counterions[4].
  • Dependent Claims: Dependent claims further specify the characteristics of the polymers, such as the types of alkyl or aryl groups and the range of carbon atoms in these groups[4].

Metrics for Measuring Patent Scope

Research suggests that patent scope can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For US5667775A, the claims are detailed and specific, suggesting a narrower scope aimed at ensuring clarity and validity[5].

Claims Breakdown

Claim 1

Claim 1 is the broadest independent claim and describes a copolymer with specific repeating units. It outlines the chemical structure, including the types of counterions and the range of carbon atoms in the alkyl or aryl groups[4].

Subsequent Claims

Subsequent claims are dependent on Claim 1 and provide additional specifications. For example, Claim 2 might specify the type of crosslinking agent used, while Claim 3 could detail the method of preparing the copolymer[4].

Patent Landscape Analysis

Technology Field

The patent falls within the technology field of pharmaceuticals and biomedical engineering, specifically focusing on oral administration of phosphate-binding polymers. This field is highly competitive, with numerous patents and ongoing innovations.

Search and Organization

To analyze the patent landscape, one would search databases such as the USPTO's Patent Public Search, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE. These searches help identify relevant patents, organize them by factors like filing date and assignee, and create visual aids like heat maps to visualize the landscape[1][3].

Trends and Key Players

The analysis reveals trends in patent filings related to phosphate-binding polymers and identifies key players in the field. Companies like Roussel Uclaf, along with other pharmaceutical and biotech firms, are significant contributors to this technological domain[3].

Citations and Evolution

Studying how patents reference each other helps understand the impact and development of the technology. US5667775A may be cited by later patents that build upon or modify its inventions, indicating its influence on subsequent research and development[3].

Insights from Patent Landscape Analysis

Technological Trends

The analysis provides insights into ongoing innovations in phosphate-binding polymers, revealing current trends and future directions in this technology. It helps identify areas of intense research activity and potential gaps in the market[3].

Competitive Landscape

Understanding the competitive landscape is crucial for strategic decision-making. The analysis shows how strong the patent portfolio of key players is and how it can gain or lose strength over time. This information is vital for inventors and companies looking to navigate the intellectual property landscape[3].

Legal Vulnerabilities

The analysis also highlights potential legal vulnerabilities. For instance, the scope and clarity of the claims in US5667775A can affect its validity and the likelihood of litigation. Narrower claims, as seen in this patent, are generally associated with higher validity and fewer legal challenges[5].

Practical Applications and Decisions

Strategic Guidance

The insights from the patent landscape analysis translate into practical guidance for strategic choices. For example, if a company is considering developing a similar phosphate-binding polymer, the analysis would help them understand the existing intellectual property landscape, identify potential competitors, and make informed decisions about their research and development efforts[3].

Licensing and Litigation

Understanding the patent scope and landscape can also inform decisions about licensing and litigation. Companies can assess the risks and opportunities associated with licensing patents or engaging in litigation to protect their intellectual property[5].

Key Takeaways

  • Patent Scope: The patent's scope is defined by its claims, which are specific and detailed, indicating a narrower scope aimed at clarity and validity.
  • Technology Field: The patent is part of the pharmaceuticals and biomedical engineering field, specifically focusing on oral administration of phosphate-binding polymers.
  • Competitive Landscape: The analysis reveals trends, key players, and potential legal vulnerabilities in the field.
  • Strategic Decisions: Insights from the patent landscape analysis provide practical guidance for strategic decisions regarding research, development, licensing, and litigation.

FAQs

Q: What is the main purpose of the phosphate-binding polymers described in US5667775A?

A: The main purpose is to remove phosphate from the gastrointestinal tract through oral administration.

Q: How can one measure the scope of a patent like US5667775A?

A: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent.

Q: What databases can be used to conduct a patent landscape analysis for US5667775A?

A: Databases like the USPTO's Patent Public Search, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE can be used.

Q: Why is it important to analyze the citations and evolution of patents in a landscape analysis?

A: Analyzing citations and evolution helps understand the impact and development of the technology, indicating how patents build upon or modify previous inventions.

Q: How can the insights from a patent landscape analysis be used in strategic decision-making?

A: Insights from the analysis can inform decisions about research and development, licensing, and litigation, helping companies navigate the intellectual property landscape effectively.

Sources

  1. USPTO: Search for patents - USPTO
  2. Google Patents: US20060258812A1
  3. Goldstein Patent Law: How to Do Patent Landscape Analysis
  4. Google Patents: US5667775A - Phosphate-binding polymers for oral administration
  5. SSRN: Patent Claims and Patent Scope

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,667,775

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,667,775

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0716606 ⤷  Subscribe CA 2002 00003 Denmark ⤷  Subscribe
European Patent Office 0716606 ⤷  Subscribe SPC/GB02/011 200210 United Kingdom ⤷  Subscribe
European Patent Office 0716606 ⤷  Subscribe SPC004/2002 Ireland ⤷  Subscribe
European Patent Office 0716606 ⤷  Subscribe C00716606/01 Switzerland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.